{"version":"1.0","provider_name":"Frankfurt Cancer Institute","provider_url":"https:\/\/fci.health\/en\/","author_name":"fci001-d","author_url":"https:\/\/fci.health\/en\/author\/fci001-d\/","title":"Clinical Translation Programs &#8226; Frankfurt Cancer Institute","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"MjOC9BE2XX\"><a href=\"https:\/\/fci.health\/en\/platform\/clinical-translation-programs\/\">Clinical Translation Programs<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/fci.health\/en\/platform\/clinical-translation-programs\/embed\/#?secret=MjOC9BE2XX\" width=\"600\" height=\"338\" title=\"&#8220;Clinical Translation Programs&#8221; &#8212; Frankfurt Cancer Institute\" data-secret=\"MjOC9BE2XX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/fci.health\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"[vc_row full_width=&#8221;stretch_row_content_no_spaces&#8221; dhsv_overflow=&#8221;vc-overflow-visible&#8221;][vc_column][dhsv_vc_header image=&#8221;538&#8243; headline=&#8221;Clinical Translation Programs&#8221;][\/vc_column][\/vc_row][vc_row dhsv_padding_bottom=&#8221;vc-padding-bottom-large&#8221;][vc_column][vc_empty_space height=&#8221;100px&#8221;][vc_empty_space height=&#8221;25px&#8221;][dhsv_vc_forschungsbereiche headtitle=&#8221;Research at the FCI&#8221; elements=&#8221;%5B%7B%22line1%22%3A%22Clinical%20Translation%20Programs%22%2C%22line2%22%3A%22Strategic%20centerpiece%20of%20the%20FCI%22%2C%22text%22%3A%22Clinical%20Translation%20Programs%20form%20the%20strategic%20core%20of%20the%20FCI.%20These%20multidisciplinary%20research%20programs%20are%20carried%20out%20by%20interdisciplinary%20teams%20consisting%20of%20researchers%20from%20clinical%20patient%20care%2C%20tumor%20biology%2C%20biochemistry%2C%20chemistry%20and%20bioinformatics.%20The%20respective%20teams%20are%20assembled%20individually%20for%20each%20clinical%20translation%20program.%20Functional%20cancer%20research%20on%20primary%20patient%20material%2C%20preclinical%20and%20clinical%20therapy%20development%20as%20well%20as%20molecular%20profiling%20of%20tumors%20work%20hand-in-hand.%22%2C%22link%22%3A%22%7C%7C%7C%22%2C%22color%22%3A%22blue%22%7D%2C%7B%22line1%22%3A%22Clinical%20Translation%20Program%201%22%2C%22line2%22%3A%22Gastrointestinal%20Tumors%22%2C%22text%22%3A%22Tumor%20response%20to%20neoadjuvant%20radiochemotherapy%20(RCT)%20shows%20a%20wide%20range%20in%20rectal%20cancer%20despite%20identical%20histology%20and%20comparable%20tumor%20stages%2C%20ranging%20from%20clinical%20(cCR)%20and%20histopathological%20complete%20remission%20(pCR)%20to%20tumor%20progression%20and%20metastasis%20under%20therapy.%20Thus%2C%20of%20great%20clinical%20importance%20for%20rectal%20and%20also%20anal%20carcinoma%20is%20to%20(1)%20understand%20the%20molecular%20causes%20of%20heterogeneous%20tumor%20response%20to%20therapy%2C%20and%20(2)%20identify%20potential%20targets%20for%20targeted%20modification%20of%20RCT%20efficacy.%20These%20challenges%20are%20addressed%20here.%22%2C%22link%22%3A%22%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Clinical%20Translation%20Program%202%22%2C%22line2%22%3A%22Molecular-stratified%20therapy%20of%20acute%20myeloid%20leukemia%22%2C%22text%22%3A%22The%20main%20focus%20of%20the%20program%20is%20on%20two%20major%20aspects%3A%20(1)%20The%20proteogenomic%20characterization%20of%20AML%20to%20explore%20clonal%20heterogeneity%2C%20and%20(2)%20The%20mechanistic%20exploration%20of%20leukemia%20cell%20metabolism%20and%20the%20resulting%20therapeutic%20consequences.%20In%20addition%2C%20we%20will%20include%20immunotherapeutic%20aspects%20in%20the%20program%2C%20which%20are%20currently%20gaining%20increasing%20importance%20in%20AML%20therapy.%20This%20will%20be%20done%2C%20for%20example%2C%20by%20designing%20innovative%20CAR%20immune%20cells%2C%20analyzing%20the%20role%20of%20the%20bone%20marrow%20environment%20on%20immune%20cell-AML%20interaction%2C%20and%20developing%20combinatorial%20treatment%20strategies.%22%2C%22link%22%3A%22%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Clinical%20Translation%20Program%203%22%2C%22line2%22%3A%22Individualized%20immunotherapeutic%20approaches%20for%20the%20Therapy%20of%20Gliomas%22%2C%22text%22%3A%22The%20overall%20goal%20of%20the%20QP%20is%20to%20further%20develop%20the%20local%20immunotherapeutic%20approaches%20towards%20individualized%20combination%20therapies%2C%20with%20the%20local%20application%20of%20specific%20therapies%20in%20the%20CNS%20or%20tumor%20as%20a%20specific%20focus.%20An%20important%20basis%20for%20this%20is%20the%20in-depth%20characterization%20of%20genetic%2C%20epigenetic%2C%20morphological%20and%20proteomic%20profiles%20of%20tumor%20cells%20and%20surrounding%20cells%20as%20part%20of%20the%20immune%20architecture%20of%20the%20tumor%20in%20close%20cooperation%20with%20the%20newly%20created%20FCI%20platform%20Immunomonitoring.%20The%20mapping%20and%20modeling%20of%20tumor%20evolution%20and%20the%20development%20of%20therapy%20resistance%20by%20bioinformatic%20methods%20and%20the%20further%20development%20and%20increased%20use%20of%20liquid%20biopsies%20represent%20further%20important%20goals%20and%20are%20prerequisites%20for%20the%20rapid%20transfer%20of%20the%20developed%20approaches%20into%20new%20clinical%20trials.%22%2C%22link%22%3A%22%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Clinical%20Translation%20Program%204%22%2C%22line2%22%3A%22Mechanisms%20of%20the%20metastatic%20cascade%20and%20development%20of%20individualized%20therapeutic%20approaches%22%2C%22text%22%3A%22Metastasis%20represents%20the%20greatest%20overall%20challenge%20in%20oncology%20and%20is%20responsible%20for%20most%20of%20the%20tumor-induced%20mortality.%20Compared%20to%20the%20rapid%20gain%20of%20knowledge%20in%20carcinogenesis%20and%20successful%20therapy%20development%20in%20major%20solid%20tumors%2C%20it%20has%20not%20yet%20been%20possible%20to%20make%20findings%20on%20the%20key%20steps%20of%20the%20metastatic%20cascade%20therapeutically%20useful.%20This%20QP%20aims%20to%20address%20this%20challenge.%20It%20integrates%20projects%20addressing%20(1)%20the%20deciphering%20of%20basic%20mechanisms%20of%20metastasis%20and%20(2)%20the%20development%20of%20experimental%20therapies%20in%20preclinical%20models.%22%2C%22link%22%3A%22%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Emerging%20field%22%2C%22line2%22%3A%22Uro-oncology%20(prostate%20and%20bladder%20cancer)%22%2C%22text%22%3A%22In%20addition%20to%20the%20clinical%20translation%20programs%20and%20the%20metastasis%20program%2C%20a%20uro-oncological%20program%20is%20currently%20being%20developed.%20The%20aim%20here%20is%20to%20experimentally%20analyze%20the%20molecular%20and%20cellular%20effects%20of%20the%20genetic%20heterogeneity%20of%20invasive%20bladder%20cancer%20(BC)%20and%20prostate%20cancer%20(PC).%20The%20focus%20of%20the%20program%20is%20on%20the%20analysis%20of%20the%20tumor%20microenvironment%20(TME)%2C%20the%20interactions%20between%20tumor%20and%20non-tumor%20cells%2C%20in%20order%20to%20improve%20the%20prediction%20of%20therapy%20success%2C%20to%20elucidate%20the%20mechanisms%20of%20metastasis%20and%20therapy%20resistance%20and%20to%20develop%20innovative%20therapeutic%20strategies.%22%2C%22color%22%3A%22gray%22%7D%5D&#8221;][\/vc_column][\/vc_row][vc_row dhsv_margin_bottom=&#8221;vc-margin-bottom-medium&#8221;][vc_column width=&#8221;1\/2&#8243;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][dhsv_vc_textwithline expandcontent=&#8221;true&#8221;]The clinical translation programs form the strategic heart of the FCI. Multidisciplinary teams consisting of clinicians, tumor biologists, biochemists, chemists and bioinformaticians work together in these interdisciplinary research projects. The teams rely on the technology platforms provided ganzen Artikel lesen..."}